U2BIO CO., LTD.

Autres langues U2Bio Co., Ltd.

Actions

A221800

KR7221800006

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 19/06/2024			Varia. 5j.	Varia. 1 janv.
3 800 ^KRW	-2,56%		-9,42%	-28,03%

2023

U2Bio Co. a déposé une demande d'introduction en bourse.

CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

U2Bio Co., Ltd. has filed an IPO.	12/04/23
Chang Moo Jeon acquired 8.5% stake in U2Bio CO. LTD. from MAC Fund, L.P. (Class B), a fund managed by M-Venture Investment, Inc. for KRW 1.6 billion.	24/09/20
U2Bio CO. LTD. announced that it has received KRW 7 billion in funding	18/04/19
U2Bio CO. LTD. announced that it expects to receive KRW 7 billion in funding	12/04/19
NDS Corporation acquired additional 11.9% stake in U2Bio CO. LTD. from BSK Potential Fund 1, fund of BSK Investment for KRW 3.8 billion.	05/10/18
NDS Corporation acquired 11.85% stake in U2Bio CO. LTD. for KRW 3.8 billion.	05/10/18
An undisclosed buyer acquired 5.26% stake in U2Bio CO. LTD. from CKD Venture Fund 4 managed by CKD Venture Capital Co., Ltd. for KRW 1.1 billion.	12/07/17
U2Bio CO. LTD. announced that it has received KRW 1.5 billion in funding	10/08/16
U2Bio CO. LTD. announced that it expects to receive KRW 1.5 billion in funding	09/08/16

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Sécurisez et Augmentez les Rendements de vos Investissements grâce à l'Accompagnement de Nos Experts

Sécuriser mes Investissements

fermer